Foghorn Therapeutics Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Sept. 20, 2024).

Foghorn Therapeutics Inc., a healthcare biotechnology company, has filed a Form 4 with the U.S. Securities and Exchange Commission (SEC) regarding changes in beneficial ownership of securities. The company's SIC code is 2834, Pharmaceutical Preparations. The SEC filing is a formal document or financial statement submitted by publicly-traded companies. For more information on this filing, readers can visit the SEC's website. [Extracted from the article]